| Identification | Back Directory | [Name]
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-((2-methylpiperidin-1-yl)sulfonyl)benzamide | [CAS]
850935-88-5 | [Synonyms]
WAY-326687
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-((2-methylpiperidin-1-yl)sulfonyl)benzamide
Benzamide, N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(2-methyl-1-piperidinyl)sulfonyl]- | [Molecular Formula]
C18H22N4O4S | [MOL File]
850935-88-5.mol | [Molecular Weight]
390.46 |
| Hazard Information | Back Directory | [Uses]
1650-M15 is an inhibitor of lipoteichoic acid synthase (LtaS). It has inhibitory activity against Gram-positive bacteria but has no significant inhibitory effect against Gram-negative bacteria. The IC50s of 1650-M15 against MRSA and MSSA are 62.44 μM and 66.42 μM, respectively, and the MICs are both 200 μM[1]. | [References]
[1] Methods and compositions for inhibiting gram positive bacteria. United States, US20150246024 A1, 2015-09-03. |
|
|